Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- ChecktodayChange DetectedThe footer revision label was updated from v3.5.4 to v3.5.5, indicating a new site release.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small software update to the page without changing visible content.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer now displays Revision: v3.5.3, signaling a new software release for the ClinicalTrials.gov page. This update is a release-level change and does not change the visible content or functionality of the page.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0. This reflects a minor version update on the page.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0. This is a minor technical update reflecting the latest site version.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This reflects a minor site update.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.